Table 6 Significant association between inflammatory bowel disease clinical outcomes and median amerindian ancestry.

From: Impact of Amerindian ancestry on clinical outcomes in Crohn’s disease and ulcerative colitis in a Latino population

Variable

N

Amerindian Ancestry Proportion

U Mann-Whitney

291

Group Yes

Group No

Yes/No

Median

Maximum

Minimum

Median

Maximun

Minimum

P Value

Diagnoses at age less than 40

167(57%)/

124(43%)

0.401

0.681

0.00001

0.384

0.568

0.155

0.03

Current use Biological Therapy

45(15%)/

246(85%)

0.366

0.577

0.00001

0.393

0.681

0.004

0.03

Prolonged* Clinical and Endoscopic Remission

31(11%)/

260(89%)

0.362

0.467

0.004

0.396

0.681

0.00001

0.0006

Surgery, anti-TNF failure, pouch, or flares in the last five years

265(91%)/

26(9%)

0.394

0.681

0.00001

0.349

0.487

0.004

0.0007

Back to article page